DLC1 Downregulation Is Linked to Fibroblast-Stellate Matrix Programs and Malignant Phenotypes in Hepatocellular Carcinoma
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Hepatocellular carcinoma (HCC) commonly arises in fibrotic, matrix-rich liver tissue, but whether reduced expression of deleted in liver cancer 1 (DLC1; STARD12) is linked to fibroblast-stellate matrix programs remains unclear. Methods We integrated TCGA-LIHC bulk transcriptomes, paired HCC tissue staining, western blotting, Huh7 knockdown assays, single-cell RNA sequencing (GSE149614) and spatial transcriptomics (GSE238264), with pan-cancer analyses used as contextual evidence. Results DLC1 was reduced in HCC, and DLC1-low bulk and fibroblast-stellate contexts were enriched for extracellular matrix, adhesion, integrin and focal-adhesion programs. Immunohistochemistry confirmed lower DLC1 protein abundance in HCC tissues, and DLC1 knockdown increased proliferation, migration and invasion in Huh7 cells. Single-cell and spatial analyses linked DLC1-low fibroblast-stellate contexts to C1/C3-like matrix programs, with higher adhesion/ECM and ECM-integrin scores in C1-like regions near C3-high regions. Conclusions These findings support an association model connecting DLC1 downregulation with malignant HCC-related phenotypes and ECM-integrin-rich fibroblast-stellate niches, without establishing a direct stromal-remodeling mechanism.
